| Literature DB >> 32281550 |
Kenichi Horisawa1, Atsushi Suzuki1.
Abstract
Cells of multicellular organisms have diverse characteristics despite having the same genetic identity. The distinctive phenotype of each cell is determined by molecular mechanisms such as epigenetic changes that occur throughout the lifetime of an individual. Recently, technologies that enable modification of the fate of somatic cells have been developed, and the number of studies using these technologies has increased drastically in the last decade. Various cell types, including neuronal cells, cardiomyocytes, and hepatocytes, have been generated using these technologies. Although most direct reprogramming methods employ forced transduction of a defined sets of transcription factors to reprogram cells in a manner similar to induced pluripotent cell technology, many other strategies, such as methods utilizing chemical compounds and microRNAs to change the fate of somatic cells, have also been developed. In this review, we summarize transcription factor-based reprogramming and various other reprogramming methods. Additionally, we describe the various industrial applications of direct reprogramming technologies.Entities:
Keywords: cell transplantation therapy; cell-fate conversion; direct reprogramming; industrial application; regenerative medicine; transcription factor
Mesh:
Year: 2020 PMID: 32281550 PMCID: PMC7247973 DOI: 10.2183/pjab.96.012
Source DB: PubMed Journal: Proc Jpn Acad Ser B Phys Biol Sci ISSN: 0386-2208 Impact factor: 3.493